Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

358 ARTÍCULOS , VIENDO DEL 286 AL 300

Why therapies for Alzheimer's disease do not work: Do we have consensus over the path to follow?

Amtul Z.

Ageing Res Rev. 2016 Jan;25:70-84. doi: 10.1016/j.arr.2015.09.003. Epub 2015 Sep 12.

Alzheimer's disease drug development based on Computer-Aided Drug Design

Zeng H, Wu X.

Eur J Med Chem. 2016 Oct 4;121:851-863. doi: 10.1016/j.ejmech.2015.08.039. Epub 2015 Sep 3.

Novel 1-Phenyl-3-hydroxy-4-pyridinone Derivatives as Multifunctional Agents for the Therapy of Alzheimer's Disease

Sheng R, Tang L, Jiang L, Hong L, Shi Y, Zhou N, Hu Y.

ACS Chem Neurosci. 2016 Jan 20;7(1):69-81. doi: 10.1021/acschemneuro.5b00224. Epub 2015 Oct 28.

A Randomized Placebo-Controlled Discontinuation Study of Cholinesterase Inhibitors in Institutionalized Patients With Moderate to Severe Alzheimer Disease

Herrmann N, O'Regan J, Ruthirakuhan M, Kiss A, Eryavec G, Williams E, Lanctôt KL.

J Am Med Dir Assoc. 2016 Feb;17(2):142-7. doi: 10.1016/j.jamda.2015.08.019. Epub 2015 Oct 9.

Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer's disease

Venigalla M, Sonego S, Gyengesi E, Sharman MJ, Münch G.

Neurochem Int. 2016 May;95:63-74. doi: 10.1016/j.neuint.2015.10.011. Epub 2015 Oct 31.

Defining the Genetic Architecture of Alzheimer's Disease: Where Next

Sims R, Williams J.

Neurodegener Dis. 2016;16(1-2):6-11. doi: 10.1159/000440841. Epub 2015 Nov 10.

Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease

Maqbool M, Mobashir M, Hoda N.

Eur J Med Chem. 2016 Jan 1;107:63-81. doi: 10.1016/j.ejmech.2015.10.018. Epub 2015 Oct 21.

Comparative study of the neuroprotective and nootropic activities of the carboxylate and amide forms of the HLDF-6 peptide in animal models of Alzheimer's disease

Bogachouk AP, Storozheva ZI, Solovjeva OA, Sherstnev VV, Zolotarev YA, Azev VN, Rodionov IL, Surina EA, Lipkin VM.

J Psychopharmacol. 2016 Jan;30(1):78-92. doi: 10.1177/0269881115616393. Epub 2015 Dec 1.

Downstream modulation of extrinsic apoptotic pathway in streptozotocin-induced Alzheimer's dementia in rats: Erythropoietin versus curcumin

Samy DM, Ismail CA, Nassra RA, Zeitoun TM, Nomair AM.

Eur J Pharmacol. 2016 Jan 5;770:52-60. doi: 10.1016/j.ejphar.2015.11.046. Epub 2015 Dec 2.

Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells

Mungenast AE, Siegert S, Tsai LH.

Mol Cell Neurosci. 2016 Jun;73:13-31. doi: 10.1016/j.mcn.2015.11.010. Epub 2015 Dec 4.

Pharmacological modulation of dietary lipid-induced cerebral capillary dysfunction: Considerations for reducing risk for Alzheimer's disease

Pallebage-Gamarallage M, Takechi R, Lam V, Elahy M, Mamo J.

Crit Rev Clin Lab Sci. 2016;53(3):166-83. doi: 10.3109/10408363.2015.1115820. Epub 2015 Dec 18.

The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis

Kobayashi H, Ohnishi T, Nakagawa R, Yoshizawa K.

Int J Geriatr Psychiatry. 2016 Aug;31(8):892-904. doi: 10.1002/gps.4405. Epub 2015 Dec 17.

Immunotherapies in Alzheimer's disease: Too much, too little, too late or off-target?

St-Amour I, Cicchetti F, Calon F.

Acta Neuropathol. 2016 Apr;131(4):481-504. doi: 10.1007/s00401-015-1518-9. Epub 2015 Dec 21.

Accelerating stem cell trials for Alzheimer's disease

Hunsberger JG, Rao M, Kurtzberg J, Bulte JWM, Atala A, LaFerla FM, Greely HT, Sawa A, Gandy S, Schneider LS, Doraiswamy PM.

Lancet Neurol. 2016 Feb;15(2):219-230. doi: 10.1016/S1474-4422(15)00332-4. Epub 2015 Dec 17.

Mechanical stress models of Alzheimer's disease pathology

Levy Nogueira M, Epelbaum S, Steyaert JM, Dubois B, Schwartz L.

Alzheimers Dement. 2016 Mar;12(3):324-33. doi: 10.1016/j.jalz.2015.10.005. Epub 2015 Dec 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias